Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter

Transplant International

Volumn 26, Issue 1, 2013, Pages 84-89

  Kim, Jong Man ^a   Kim, Gaab Soo ^a   Joh, Jae Won ^a   Suh, Kyung Suk ^b   Park, Jae Berm ^a   Ko, Justin Sangwook ^a   Kwon, Choon Hyuck David ^a   Yi, Nam Joon ^b   Gwak, Mi Sook ^a   Lee, Kwang Woong ^b   Kim, Sung Joo ^a   Lee, Suk Koo ^a  

^a Sungkyunkwan University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

hepatocellular carcinoma; intraoperative blood salvage; leukocyte depletion filter; living donor liver transplantation; tumor recurrence

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; ASCITES; AUTOTRANSPLANTATION; BACTERIAL INFECTION; BLOOD SALVAGE; CANCER RECURRENCE; CANCER RISK; CATHETER COMPLICATION; ERYTHROCYTE FILTERABILITY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REOPERATION; SURVIVAL RATE; URINARY TRACT INFECTION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAOPERATIVE PERIOD; LEUKOCYTE REDUCTION PROCEDURES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; OPERATIVE BLOOD SALVAGE; RETROSPECTIVE STUDIES;

EID: 84871281559     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12001     Document Type: Article

References (29)

1. Ozier Y, Albi A,. Liver transplant surgery and transfusion. Int Anesthesiol Clin 2004; 42: 147.
2. Hendriks HG, van der Meer J, Klompmaker IJ, et al,. Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11 (Suppl. 1): S87.
3. Ramos E, Dalmau A, Sabate A, et al,. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320.
4. Chamberland ME,. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002; 34: 797.
5. Benson AB, Burton JR Jr, Austin GL, et al,. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17: 149.
6. Yuasa T, Niwa N, Kimura S, et al,. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion 2005; 45: 879.
7. Boin IF, Leonardi MI, Luzo AC, Cardoso AR, Caruy CA, Leonardi LS,. Intraoperative massive transfusion decreases survival after liver transplantation. Transplant Proc 2008; 40: 789.
8. Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma-is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res 2011; 47: 182.
9. Phillips SD, Maguire D, Deshpande R, et al. A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. Transplantation 2006; 81: 536.
10. Autologous blood transfusions. Council on Scientific Affairs. JAMA 1986; 256: 2378.
11. Fruhauf NR, Dumpich O, Kaudel CP, Kasimir-Bauer S, Oldhafer KJ,. Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Perfusion 2001; 16 (Suppl.): 51.
12. Gwak MS, Lee KW, Kim SY, et al. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transpl 2005; 11: 331.
13. Liang TB, Li DL, Liang L, et al. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation 2008; 85: 863.
14. Kinoshita Y, Udagawa H, Tsutsumi K, et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000; 127: 185.
15. Nieder AM, Manoharan M, Yang Y, Soloway MS,. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007; 69: 881.
16. Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H,. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 2005; 11: 293.
17. Karczewski DM, Lema MJ, Glaves D,. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg 1994; 78: 1131.
18. Denis MG, Lipart C, Leborgne J, et al. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997; 74: 540.
19. Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996; 68: 739.
20. Fujimoto J, Okamoto E, Yamanaka N, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg 1993; 128: 1065.
21. Zulim RA, Rocco M, Goodnight JE Jr., Smith GJ, Krag DN, Schneider PD,. Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe? Arch Surg 1993; 128: 206.
22. Muscari F, Suc B, Vigouroux D, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int 2005; 18: 1236.
23. Futamura N, Nakanishi H, Hirose H, Nakamura S, Tatematsu M,. The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg 2005; 71: 585.
24. Miller GV, Ramsden CW, Primrose JN,. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. Br J Surg 1991; 78: 713.
25. Perseghin P, Vigano M, Rocco G, Della Pona C, Buscemi A, Rizzi A,. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang 1997; 72: 221.
26. Torre GC, Ferrari M, Favre A, Razzetta F, Borgonovo G,. A new technique for intraoperative blood recovery in the cancer patient. Eur J Surg Oncol 1994; 20: 565.
27. Update Concensus Conference on Autologous Transfusion. Edinburgh: Royal College of Physicians of Edinburgh, 1998.
28. Intraoperative Red Blood Cell Salvage During Radical Prostatectomy or Radical Cystectomy. London: NICE; 2008. Available at: http://guidance.nice.org. uk/IPG258/Guidance/pdf/English (accessed 25 July 2010).
29. Waters JH, Donnenberg AD,. Blood salvage and cancer surgery: should we do it? Transfusion 2009; 49: 2016.